Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
radiopharmaceuticals
Farr (1989) Ramon v. Farr Approved Drugs for Off-Label (Unlabeled) Indications
rebates
recordkeeping
red yeast rice
refills authorization of dispensing of prescriptions multiple refills written on same day authorization of long-term care facilities schedule III, IV, and V substances
registration, CSA applications for dispensing exemptions modification, transfer, or termination separate registrations denial, revocation, or suspension distribution manufacturing research with controlled substance
regulation approaches of managed care plan formularies reasons for for outcomes of prescription drug samples State Regulation of Third-Party Plans
reimbursement for drugs
See risk evaluation and mitigation strategies (REMS) Bibliography Food and Drug Administration Amendments Act of 2007 New Drug Approval Prescription Drug Labeling Information for the Patient See risk evaluation and mitigation strategies (REMS) Useful Written Patient Information and Medication Guides Drug Price Competition and Patent Term Restoration Act of 1984 Historical Overview of the Federal Food, Drug, and Cosmetic Act Preface Purpose of a Controlled Substance Prescription The Road to an Approved New Drug Application
repackaging drugs adulteration regulations manufacturing, defined Food, Drug, and Cosmetic Act offenses
research, with controlled substance
reasonable safeguards
recalls
red flags
refill reminder exception
registration number, DEA
reimportation of drugs
Renacidin
reregistration, applications for
Res ipsa loquitur
retail community pharmacy
retrospective review, drug use review
Riegel v. Medtronic, Inc. (2008)
right-to-try laws
risk evaluation and mitigation strategies (REMS) FDA Safety and Innovation Act of 2012 Drug Information Website for Consumers and Health Professionals: Drugs@FDA The Road to an Approved New Drug Application
risk management continuous quality improvement programs institutional controls malpractice overview pharmacist as risk manager rules for Continuous Quality Improvement Programs as Risk Management malpractice insurance overview problems and pitfalls of strategies
Rite Aid
Rite Aid of New Jersey, Inc. v. Board of Pharmacy (1973)
Robinson-Patman Act (1936) aftermath of portland decision competing buyers and injury to competition Nonprofit Institutions Act “own use” doctrine brand-name prescription drugs antitrust litigation meeting competition defense The Robinson-Patman Act